日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies

加拿大早期应用Tarlatamab(T细胞衔接器)治疗广泛期小细胞肺癌(ES-SCLC)的经验:教训和实施策略

Cheema, Parneet K; Perdrizet, Kirstin A; Sangha, Randeep S; Breadner, Daniel; Daaboul, Nathalie; Farley, Shannon; Jao, Kevin; Liu, Geoffrey; Logan, Becky; Melosky, Barbara; Reiman, Anthony; Snow, Stephanie; Yadav, Sunil; Kassam, Shaqil

Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit

儿童国家免疫规划中延迟过渡到20价肺炎球菌结合疫苗:公共卫生和经济效益的损失

Perdrizet, Johnna; Ta, An; Huang, Liping; Wannaadisai, Warisa; Ilic, Aleksandar; Hayford, Kyla; Sabra, Ayman

Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme

荷兰儿童国家免疫规划中过渡到20价肺炎球菌结合疫苗的经济评估

Çakar, Esra; Ta, An; Peters, Michel; Vinand, Elizabeth; Waterval-Overbeek, Angela; Ilic, Aleksandar; Perdrizet, Johnna

Indirect Comparison of PCV20 Immunogenicity with PCV10 in Pediatric 3 + 1 and 2 + 1 Schedules

PCV20 与 PCV10 在儿童 3+1 和 2+1 接种方案中的免疫原性间接比较

Dunne, Eileen M; Struwig, Valda A; Lowe, Wing; Wilson, Claire H; Perdrizet, Johnna E; Tamimi, Noor; Hayford, Kyla; Jodar, Luis; Gessner, Bradford D; Theilacker, Christian

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population

法国儿童人群从低价肺炎球菌结合疫苗过渡到20价肺炎球菌结合疫苗的成本效益分析

Fiévez, Stéphane; Ta, An; Bellier, Lucile; Blanc, Emmanuelle; El Khoury, Jessica Y; Beillat, Maud; Sabra, Ayman; Sivignon, Marine; Ilic, Aleksandar; Perdrizet, Johnna

Impact of the COVID-19 Pandemic on Diagnosis and Multidisciplinary Treatment of NSCLC in Ontario, Canada

新冠疫情对加拿大安大略省非小细胞肺癌诊断和多学科治疗的影响

Perdrizet, Kirstin; Le, Lisa W; Lau, Anthea; Tai, Xiaochen; Rabey, Mary R; Law, Jennifer H; Maziak, Donna; Leighl, Natasha

Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada

加拿大转移性癌症患者及时、公平地开展先进生物标志物检测

Sheffield, Brandon S; Banerji, Shantanu; Chankowsky, Allen; Dudani, Shaan; Gill, Sharlene; Gorski, Zuzanna; Kassam, Shaqil; Macaulay, Cassandra; Manna, Mita; Perdrizet, Kirstin; Ramjeesingh, Ravi; D'Angelo, Monika Slovinec; Servidio-Italiano, Filomena

Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis

PCV20疫苗预防儿童肺炎球菌疾病的成本效益分析:一项基于德国社会视角的分析

Ta, An; Kühne, Felicitas; Laurenz, Maren; von Eiff, Christof; Warren, Sophie; Perdrizet, Johnna

Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece

德国、法国、西班牙和希腊的医护人员和照护者对儿童肺炎球菌结合疫苗及其接种方案的认知

Perdrizet, Johnna E; Rozenbaum, Mark H; Heffler, Matthew J

Point of Care Liquid Biopsy for Cancer Treatment-Early Experience from a Community Center

癌症治疗中的即时液体活检——来自社区中心的早期经验

Nicholas, Champica; Beharry, Andrea; Bendzsak, Anna M; Bisson, Kassandra R; Dadson, Keith; Dudani, Shaan; Iafolla, Marco; Irshad, Kashif; Perdrizet, Kirstin; Raskin, William; Singh, Raviya; Tsui, David Chun Cheong; Wang, Xin; Yeung, Ching; Cheema, Parneet K; Sheffield, Brandon S